Company news
Paxman AB news in 2025
Paxman AB's news releases, calls and decks from 2025, newest first.
PAXMAN announces 510k Submission to the U.S. Food and Drug Administration (FDA) for the Paxman Cryocompression Device to Prevent Chemotherapy-Induced Peripheral Neuropathy (CIPN)
December 31, 2025
Paxman announces that CMS has finalized the 2026 Medicare payment rates for mechanical scalp cooling under the Hospital Outpatient and Physician Fee Schedule.
November 24, 2025
PAXMAN publishes its interim report for Q3 2025
November 14, 2025
Paxman announces progress of its Clinical Trial for Chemotherapy Induced Peripheral Neuropathy, with latest data presented at EONS18 Conference part of ESMO® Congress 2025
October 20, 2025
PAXMAN announces the acceptance of the Paxman Limb Cryocompression System (PLCS) into the FDA’s Safer Technologies Program (STeP).
October 17, 2025
Kvartalsrapport Q2 2025
August 20, 2025
PAXMAN publishes its interim report for Q2 2025
August 20, 2025
Outpatient Prospective Payment System (OPPS) Proposed Rule Assigns 2026 Payment Rates for Mechanical Scalp Cooling
July 16, 2025